Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

Evaluation of the Role of Connected Scales in the Therapeutic Care of Hematology Patients

NCT06133426

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Cochin Hospital Paris, France

View Trial Details

Recruiting

Vaccine Responses in Patient With Multiple Myeloma and Non-Hodgkin Lymphoma After CAR-T Treatment

NCT06784167

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +33 more
Locations: OHSU Knight Cancer Institute Portland, Oregon, United States

View Trial Details

Recruiting

Observational Study on the Combination of Selinexor With Bortezomib and Dexamethasone for the Treatment of MM Patients

NCT06933277

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Aou Careggi - Sod Ematologia Florence, Italy

View Trial Details

Recruiting

Prognostic Value of Circulating Tumoral DNA After the First 6 Months of Treatment in Patients With Waldenström Macroglobulinemia

NCT04893564

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: CHU Amiens Amiens, France

View Trial Details

Recruiting

This Study Aims to Clarify the Prevalence and Characteristics of Neuropathy, Along With Associated Paraclinical Findings in Patients With Waldenström's Macroglobulinemia (WM) in a Cohort of WM Patients to Optimize the Diagnostic Process

NCT07160270

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +18 more
Locations: Copenhagen Neuromuscular Center, Rigshospitalet Blegdamsvej. København Ø, Denmark

View Trial Details

Recruiting

A Study to Evaluate Safety, Drug Levels and Effectiveness of CC-92480 (BMS-986348) in Combination With Other Treatments in Participants With Relapsed or Refractory Multiple Myeloma

NCT05372354

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: UAB Comprehensive Cancer Center Birmingham, Alabama, United States

Johns Hopkins Medicine - The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

John Theurer Cancer Center at Hackensack UMC Hackensack, New Jersey, United States

View all 17 locations

View Trial Details

Recruiting

Early Assessment of Cardiac Function After Treatment With CAR-T Cells

NCT06350994

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Car T- Cell, +33 more
Locations: Critical care medicine department Paris, France

View Trial Details

Recruiting

Belantamab Mafodotin, Pomalidomide and Dexamethasone for the Treatment of High-Risk Myeloma

NCT05208307

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Emory University/Winship Cancer Institute Atlanta, Georgia, United States

View Trial Details

Recruiting

Factors Associated With Health-related Quality of Life and Social Participation of Patients With Multiple Myeloma and Their Caregivers

NCT07014865

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations: Azienda Unità Sanitaria Locale Reggio Emilia - IRCCS Reggio Emilia, RE, Italy

View Trial Details

Recruiting

Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors

NCT06908629

Conditions: Blood Protein Disorders, Cancer, Cancer Survivors, +25 more
Locations: Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions